Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

biofactura.com

Founded Year

2003

Stage

Series B | Alive

Total Raised

$7.8M

Last Raised

$6M | 3 yrs ago

About BioFactura

BioFactura develops and commercializes biodefense drugs, client-selected drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal choice for bringing these drugs to market with faster, lower cost, superior-quality manufacture. The company was founded in 2003 and is based in Frederick, Maryland.

BioFactura Headquarters Location

8435 Progress Dr. Suite Z

Frederick, Maryland, 21701,

United States

301-315-8002

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioFactura

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioFactura is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

BioFactura Patents

BioFactura has filed 3 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Coagulation system
  • EC 3.4.21
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/27/2016

9/15/2020

Molecular biology, Biotechnology, Genetics, Genetic engineering, Gene delivery

Grant

Application Date

4/27/2016

Grant Date

9/15/2020

Title

Related Topics

Molecular biology, Biotechnology, Genetics, Genetic engineering, Gene delivery

Status

Grant

Latest BioFactura News

In Conversation: Rodeina Challand, VP Scientific Affairs, BioFactura

Aug 15, 2022

A key recent hire at Frederick-based BioFactura was biosimilars and scientific affairs expert Rodeina Challand, who joined the BioFactura team as its new VP of Scientific Affairs in late 2021. We caught up with Challand to discuss her background, the biosimilars market landscape, and why she’s excited about what’s next for BioFactura.  The post In Conversation: Rodeina Challand, VP Scientific Affairs, BioFactura appeared first on BioBuzz.

BioFactura Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BioFactura Rank

  • When was BioFactura founded?

    BioFactura was founded in 2003.

  • Where is BioFactura's headquarters?

    BioFactura's headquarters is located at 8435 Progress Dr., Frederick.

  • What is BioFactura's latest funding round?

    BioFactura's latest funding round is Series B.

  • How much did BioFactura raise?

    BioFactura raised a total of $7.8M.

  • Who are the investors of BioFactura?

    Investors of BioFactura include Wilson Sonsini Goodrich & Rosati, The University of Vermont Health Network Ventures, Jeffrey Hausfeld and Frederick Innovative Technology Center.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.